These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3513752)

  • 1. Arousal and stability: the effects of five new sympathomimetic drugs suggest a new principle for the prevention of space motion sickness.
    Kohl RL; Calkins DS; Mandell AJ
    Aviat Space Environ Med; 1986 Feb; 57(2):137-43. PubMed ID: 3513752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of phosphatidylcholine in the modulation of motion sickness susceptibility.
    Kohl RL; Ryan P; Homick JL
    Aviat Space Environ Med; 1985 Feb; 56(2):125-8. PubMed ID: 3985888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effective intensity of Coriolis, cross-coupling stimulation is gravitoinertial force dependent: implications for space motion sickness.
    Lackner JR; Graybiel A
    Aviat Space Environ Med; 1986 Mar; 57(3):229-35. PubMed ID: 3485968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What you thought you knew about motion sickness isn't necessarily so.
    Cowings PS; Malmstrom FV
    Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine correlates of susceptibility to motion sickness.
    Kohl RL
    Aviat Space Environ Med; 1985 Dec; 56(12):1158-65. PubMed ID: 3002315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
    Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of histaminergic drugs in experimental motion sickness.
    Matsnev EI; Sigaleva EE
    J Vestib Res; 2007; 17(5-6):313-21. PubMed ID: 18626141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of motion sickness in orbital flight.
    Graybiel A
    Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human assay of antimotion sickness drugs.
    Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
    Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elicitation of motion sickness by head movements in the microgravity phase of parabolic flight maneuvers.
    Lackner JR; Graybiel A
    Aviat Space Environ Med; 1984 Jun; 55(6):513-20. PubMed ID: 6466247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of space sickness in shuttle-orbiter missions.
    Graybiel A
    Aviat Space Environ Med; 1979 Feb; 50(2):171-6. PubMed ID: 36067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration.
    Kohl RL
    Aviat Space Environ Med; 1987 Feb; 58(2):125-31. PubMed ID: 3827787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man.
    Kohl RL; Homick JL; Cintron N; Calkins DS
    Aviat Space Environ Med; 1987 Dec; 58(12):1171-4. PubMed ID: 3122717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for nonsedating antihistamines in motion sickness? Fallout from space research may soon benefit your patients.
    Kohl RL
    J Respir Dis; 1991 Apr; 12(4 Suppl):S17-21. PubMed ID: 11542203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of the preparation Gavinton in preventing motion sickness].
    Bodo D; Kotovskaia AR; Galle RR; Gavrilova LN; Gusakova GA
    Kosm Biol Aviakosm Med; 1982; 16(3):49-51. PubMed ID: 7098411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of skin potential level and of skin resistance level corresponding to lasting motion discomfort.
    Isu N; Koo J; Takahashi N
    Aviat Space Environ Med; 1987 Feb; 58(2):136-42. PubMed ID: 3827789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aminalon as an agent for the prevention of motion sickness].
    Lapaev EV; Voinova II; Vorob'ev OA; Barmicheva NM
    Zh Ushn Nos Gorl Bolezn; 1978; (5):35-9. PubMed ID: 360685
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of direction of head movement on motion sickness caused by Coriolis stimulation.
    Woodman PD; Griffin MJ
    Aviat Space Environ Med; 1997 Feb; 68(2):93-8. PubMed ID: 9125096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of overt motion sickness by incremental exposure to otherwise highly stressful Coriolis accelerations. NAMI-1044.
    Graybiel A; Deane FR; Colehour JK
    NASA Contract Rep NASA CR; 1968 May; ():1-13. PubMed ID: 5303710
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrogastrograms during motion sickness in fasted and fed subjects.
    Stewart JJ; Wood MJ; Wood CD
    Aviat Space Environ Med; 1989 Mar; 60(3):214-7. PubMed ID: 2712799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.